Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.88 USD | +1.42% | -11.78% | -40.86% |
Business Summary
Number of employees: 94
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Monoclonal Antibody
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -82.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -82.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 23-10-29 | |
Seth Harmon
DFI | Director of Finance/CFO | 45 | 23-04-30 |
Thomas Ciulla
CTO | Chief Tech/Sci/R&D Officer | 59 | 22-12-31 |
Chief Operating Officer | 55 | 23-10-29 | |
Angela Sheen
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Shan Wu
PRN | Corporate Officer/Principal | - | 23-10-29 |
Vahe Bedian
PRN | Corporate Officer/Principal | - | 20-10-27 |
Anthony Casciano
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 18-01-02 |
Tomas Kiselak
CHM | Chairman | 38 | 20-10-27 |
Chief Executive Officer | 53 | 23-10-29 | |
Peter Harwin
BRD | Director/Board Member | 38 | 20-10-27 |
Jennifer Moses
BRD | Director/Board Member | 49 | 21-07-13 |
Sarah Gheuens
BRD | Director/Board Member | 45 | 23-09-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 172,435 | 0 | 0 | 92.57 % |
Stock B | 0 | 143,522 | 0 | 0 | |
Stock C | 1 | 62,767,570 | 58,104,337 ( 92.57 %) | 0 |
Company contact information
Viridian Therapeutics, Inc.
221 Crescent Street Suite 401
02453, Waltham
+
http://www.viridiantherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.86% | 822M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- VRDN Stock
- Company Viridian Therapeutics, Inc.